What is the appropriate treatment for beta‑blocker overdose?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Beta-Blocker Overdose

For life-threatening beta-blocker overdose with hypotension, initiate vasopressors immediately, then add high-dose insulin therapy (Class I recommendation). 1

Initial Management Algorithm

Supportive Care Foundation

  • Monitor and treat hypoglycemia with supplemental dextrose as standard care, as beta-blocker poisoning can cause hypoglycemia 1
  • Establish continuous cardiac monitoring and hemodynamic support
  • Consider activated charcoal for GI decontamination in select early presentations 2

First-Line Pharmacologic Therapy

For hypotension (Class I recommendations):

  1. Vasopressors - Start immediately as they are readily available and act quickly 1
  2. High-dose insulin - Administer for hypotension refractory to vasopressors OR in conjunction with vasopressor therapy 1
    • High-dose insulin improves inotropy in cardiogenic shock
    • Associated with lower rates of vasoconstrictive complications compared to vasopressor-only therapy 1

For bradycardia or hypotension (Class IIa recommendation):

  • Glucagon bolus followed by continuous infusion - Increases contractility and improves hemodynamics 1

Second-Line Therapies

For beta-blocker-induced bradycardia (Class IIb recommendations):

  • Atropine may be reasonable 1
  • Electrical pacing may be reasonable 1

Agent-Specific Considerations

For atenolol or sotalol poisoning specifically:

  • Hemodialysis may be reasonable for life-threatening toxicity (Class IIb) 1
  • The EXTRIP workgroup suggests hemodialysis for patients with impaired kidney function experiencing refractory bradycardia and hypotension from atenolol or sotalol 3
  • For sotalol specifically: monitor for QT prolongation and torsades de pointes; hemodialysis can be life-saving even in patients with normal renal function 4

For propranolol overdose:

  • Expect potential CNS manifestations (delirium, coma, seizures) and sodium channel blockade effects causing ventricular dysrhythmias 2
  • Propranolol is NOT dialyzable due to high lipophilicity 3

Refractory Cases

For cardiogenic shock refractory to pharmacological interventions (Class IIa recommendation):

  • VA-ECMO is reasonable and may be life-saving 1, 5
  • Consider early consultation for ECMO in patients not responding to maximal medical therapy

What NOT to Use

Intravenous lipid emulsion (ILE) therapy:

  • NOT recommended (Class III: No Benefit) - not likely to be beneficial for life-threatening beta-blocker poisoning 1

Critical Pitfalls to Avoid

  1. Don't delay vasopressors - They should be the initial therapy for beta-blocker-induced hypotension given immediate availability 1

  2. Don't use high-dose insulin alone - It should be given refractory to OR in conjunction with vasopressors, not as monotherapy 1

  3. Don't assume all beta-blockers are dialyzable - Only atenolol and sotalol benefit from hemodialysis; propranolol is non-dialyzable 3

  4. Don't overlook agent-specific toxicity - Sotalol causes QT prolongation and torsades de pointes requiring specific monitoring and management 4, 2

  5. Don't wait too long for ECMO - In refractory cardiogenic shock despite maximal therapy, early ECMO consultation improves outcomes 1, 5

Disposition

All patients with beta-blocker overdose causing hemodynamic instability require ICU admission for close hemodynamic monitoring 2. Cardiovascular symptoms typically appear within 2 hours of ingestion for immediate-release formulations, 8 hours for sustained-release, and 12 hours for sotalol 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.